Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexual Dysfunctions, Psychological 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Granulosa cell tumor of the ovary 1 Endometrial Neoplasms 1 Breast Carcinoma In Situ 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Breast Cancer 1

Interventions

Tamoxifen 4 Specimen Handling 4 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Radiotherapy 1 Radiation 1 Omacor 1 Observation 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Laser Therapy 1 Biopsy 1 Anastrozole 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × exemestane × 30 days × Clear all

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡